28079476|t|Mimiviruses and the Human Interferon System: Viral Evasion of Classical Antiviral Activities, But Inhibition By a Novel Interferon-β Regulated Immunomodulatory Pathway
28079476|a|In this review we discuss the role of mimiviruses as potential human pathogens focusing on clinical and evolutionary evidence. We also propose a novel antiviral immunomodulatory pathway controlled by interferon-β (IFN-β) and mediated by immune-responsive gene 1 (IRG1) and itaconic acid, its product. Acanthamoeba polyphaga Mimivirus (APMV) was isolated from amoebae in a hospital while investigating a pneumonia outbreak. Mimivirus ubiquity and role as protist pathogens are well understood, and its putative status as a human pathogen has been gaining strength as more evidence is being found. The study of APMV and human cells interaction revealed that the virus is able to evade the IFN system by inhibiting the regulation of interferon -stimulated genes, suggesting that the virus and humans have had host-pathogen interactions. It also has shown that the virus is capable of growing on IFN-α2, but not on IFN-β - treated cells, hinting at an exclusive IFN-β antiviral pathway. Our hypothesis based on preliminary data and published articles is that IFN-β preferentially upregulates IRG1 in human macrophagic cells, which in turn produces itaconic acid. This metabolite links metabolism to antiviral activity by inactivating the virus, in a novel immunomodulatory pathway relevant for APMV infections and probably to other infectious diseases as well.
28079476	0	11	Mimiviruses	T005	C1671055
28079476	20	25	Human	T016	C0086418
28079476	26	36	Interferon	T116,T121,T129	C3652465
28079476	37	43	System	T022	C0020962
28079476	45	58	Viral Evasion	T043	C1154492
28079476	62	71	Classical	T169	C0443177
28079476	72	92	Antiviral Activities	T040	C1155328
28079476	98	108	Inhibition	T052	C3463820
28079476	120	132	Interferon-β	T116,T121,T129	C0015980
28079476	133	142	Regulated	T038	C1327622
28079476	143	159	Immunomodulatory	T061	C1963758
28079476	160	167	Pathway	T077	C1705987
28079476	176	182	review	T170	C0282443
28079476	198	202	role	T077	C1705810
28079476	206	217	mimiviruses	T005	C1671055
28079476	221	230	potential	T080	C3245505
28079476	231	236	human	T016	C0086418
28079476	237	246	pathogens	T001	C0450254
28079476	259	267	clinical	T080	C0205210
28079476	272	284	evolutionary	T045	C0015219
28079476	285	293	evidence	T078	C3887511
28079476	303	310	propose	T080	C1553874
28079476	319	328	antiviral	T040	C1155328
28079476	329	345	immunomodulatory	T121,T129	C0005525
28079476	346	353	pathway	T077	C1705987
28079476	354	364	controlled	T169	C2587213
28079476	368	380	interferon-β	T116,T121,T129	C0015980
28079476	382	387	IFN-β	T116,T121,T129	C0015980
28079476	405	429	immune-responsive gene 1	T116,T123	C3253749
28079476	431	435	IRG1	T116,T123	C3253749
28079476	441	454	itaconic acid	T109	C0064110
28079476	460	467	product	T071	C1514468
28079476	469	501	Acanthamoeba polyphaga Mimivirus	T005	C1644952
28079476	503	507	APMV	T005	C1644952
28079476	513	521	isolated	T169	C0205409
28079476	527	534	amoebae	T204	C0002642
28079476	540	548	hospital	T073,T093	C0019994
28079476	555	568	investigating	T169	C1292732
28079476	571	580	pneumonia	T047	C0032285
28079476	581	589	outbreak	T067	C0012652
28079476	591	600	Mimivirus	T005	C1671055
28079476	601	609	ubiquity	T080	C0205556
28079476	614	618	role	T077	C1705810
28079476	622	629	protist	T001	C0597305
28079476	630	639	pathogens	T001	C0450254
28079476	669	677	putative	T082	C0205124
28079476	678	684	status	T169	C1442792
28079476	690	695	human	T016	C0086418
28079476	696	704	pathogen	T001	C0450254
28079476	714	721	gaining	T081	C1517378
28079476	722	730	strength	T078	C0808080
28079476	739	747	evidence	T078	C3887511
28079476	768	773	study	T062	C2603343
28079476	777	781	APMV	T005	C1644952
28079476	786	791	human	T016	C0086418
28079476	792	797	cells	T025	C0007634
28079476	798	809	interaction	T040	C1752856
28079476	828	833	virus	T005	C1671055
28079476	845	850	evade	T040	C1654934
28079476	855	858	IFN	T116,T121,T129	C0021747
28079476	859	865	system	T022	C0020962
28079476	869	879	inhibiting	T052	C3463820
28079476	884	894	regulation	T045	C0017263
28079476	898	908	interferon	T116,T121,T129	C3652465
28079476	921	926	genes	T028	C0017337
28079476	948	953	virus	T005	C1671055
28079476	958	964	humans	T016	C0086418
28079476	974	1000	host-pathogen interactions	T040	C1752856
28079476	1029	1034	virus	T005	C1671055
28079476	1038	1045	capable	T080	C2698977
28079476	1060	1066	IFN-α2	T116,T129	C2937361
28079476	1079	1084	IFN-β	T116,T121,T129	C0015980
28079476	1087	1094	treated	T169	C1522326
28079476	1095	1100	cells	T025	C0007634
28079476	1116	1125	exclusive	T078	C1548966
28079476	1126	1131	IFN-β	T116,T121,T129	C0015980
28079476	1132	1141	antiviral	T040	C1155328
28079476	1142	1149	pathway	T077	C1705987
28079476	1155	1165	hypothesis	T078	C1512571
28079476	1166	1171	based	T078	C1705938
28079476	1175	1191	preliminary data	T078	C1548161
28079476	1196	1214	published articles	T170	C1706852
28079476	1223	1228	IFN-β	T116,T121,T129	C0015980
28079476	1229	1243	preferentially	T078	C0558295
28079476	1244	1255	upregulates	T044	C0041904
28079476	1256	1269	IRG1 in human	T116,T123	C3253749
28079476	1270	1287	macrophagic cells	T025	C0024432
28079476	1312	1325	itaconic acid	T109	C0064110
28079476	1332	1342	metabolite	T123	C0870883
28079476	1349	1359	metabolism	T040	C0025519
28079476	1363	1381	antiviral activity	T040	C1155328
28079476	1385	1397	inactivating	T169	C0544461
28079476	1402	1407	virus	T005	C1671055
28079476	1420	1436	immunomodulatory	T061	C1963758
28079476	1437	1444	pathway	T077	C1705987
28079476	1445	1453	relevant	T080	C2347946
28079476	1458	1462	APMV	T005	C1644952
28079476	1463	1473	infections	T046	C3714514
28079476	1496	1515	infectious diseases	T047	C0009450